Exclusive: Ocugen plans to sell 100 million Indian vaccine doses in the US by 2021
NEW DELHI (Reuters) – Ocugen Inc plans to sell 100 million doses of state-backed COVID-19 vaccine in the United States this year, U.S. company chief executive Shankar Musunuri told Reuters on…
